Molecular Imaging: Page 467

Dual-phase PET/CT useful in lung nodule assessment

By Eric Barnes

The use of dual-phase PET/CT can help distinguish benign from malignant lung nodules when F-18 FDG uptake is low, according to a new study from Korea. A group from the National University of Pusan sought to assess the utility of dual-phase PET/CT to differentiate benign from malignant lung disease with low F-18 FDG uptake.

April 3, 2007

ACRIN to launch new PET trial

By AuntMinnie.com staff writers

The American College of Radiology Imaging Network (ACRIN) is planning a new clinical trial, designed to prospectively validate if FDG can serve as predictive marker of tumor response and patient outcome in non-small cell lung cancer (NSCLC) patients.

April 2, 2007

MRI pioneer Lauterbur dies

Paul Lauterbur, Ph.D., who received the Nobel Prize for his role in developing MRI, died on Tuesday at his home in Illinois of kidney disease. He was 77.

March 29, 2007

Rubidium PET/CT shows potential for coronary artery disease diagnosis

By Jonathan S. Batchelor

While molecular imaging for coronary artery disease (CAD) with SPECT or PET is accurate, diagnosis of multivessel CAD has proved difficult with these modalities. A team of researchers from Brigham and Women's Hospital in Boston may have found a way to address the insufficiencies of multivessel CAD diagnosis by utilizing rubidium (Rb-82) PET/CT to determine a value for vasodilator left ventricular ejection fraction (LVEF) reserve.

March 29, 2007

SNM advances 'Bench to Bedside' campaign

By AuntMinnie.com staff writers

The SNM reported today that it has received nearly $3.3 million in corporate donations for its "Bench to Bedside" campaign, a five-year effort to raise $5 million to translate molecular imaging research into healthcare innovations that can be used in patient care.

March 28, 2007

Dilon sales grow in Q4

By AuntMinnie.com staff writers

Gamma camera developer Dilon Technologies of Newport News, VA, said that its fiscal 2006 fourth quarter saw strong sales for its breast-specific gamma camera.

March 27, 2007

IsoRay scores additional financing

By AuntMinnie.com staff writers

Medical isotope developer IsoRay Medical has closed on $16.5 million in equity financing.

March 22, 2007

AnazaoHealth provides teddy bears for pediatric I-123 MIBG patients

By AuntMinnie.com staff writers

The nuclear medicine division of AnazaoHealth has launched a program to provide a teddy bear to each child patient receiving an iodine-123 metaiodobenzylguanidine (I-123 MIBG) dose.

March 22, 2007

Avid releases results for PET Alzheimer's agent

By AuntMinnie.com staff writers

Molecular imaging developer Avid Radiopharmaceuticals of Philadelphia has released results of the company's first clinical study of a new radiopharmaceutical designed to provide PET imaging of Alzheimer's disease.

March 22, 2007

SPECT/CT offers on-target diagnosis in noncancerous bone disease

By Shalmali Pal

There's no shortage of research on SPECT/CT in oncologic imaging and the fact that bone scintingraphy has its limitations in this setting. But what about patients who are referred for nononcologic imaging? Is bone scintigraphy any more useful? No, according to nuclear medicine specialists from Israel, who advocated using SPECT plus multislice low-dose CT (MslCT) instead.

March 22, 2007

Siemens, M. D. Anderson boost collaboration

By AuntMinnie.com staff writers

Siemens Medical Solutions said that it has expanded its molecular imaging research collaboration with the University of Texas M. D. Anderson Cancer Center with the establishment of a preclinical research center dedicated to the development of new, targeted biomarkers.

March 21, 2007

MDS Nordion to expand Belgian FDG facility

By AuntMinnie.com staff writers

Radioisotope developer MDS Nordion of Kanata, Ontario, is investing $5.8 million (U.S.) to expand its production facility in Fleurus, Belgium, to meet the demand for the imaging agent fluorine-18 fluorodeoxyglucose (F-18 FDG).

March 21, 2007

Previous Page

Page 467 of 615

Next Page